calendar
4,563 catalysts · 4,494 phase readout · 2,304 8k filing · 282 earnings · 172 phase 2 completion · 73 phase 1 completion · 68 pdufa
4,563 catalysts · 4,494 phase readout · 2,304 8k filing · 282 earnings · 172 phase 2 completion · 73 phase 1 completion · 68 pdufa
Sponsor: Inmagene LLC. Phase: PHASE1. Conditions: Alopecia Areata (AA)
Sponsor: Aktiia SA. Phase: NA. Conditions: Blood Pressure
Sponsor: Al-Azhar University. Phase: PHASE4. Conditions: Brachial Plexus Blocks
Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma
Sponsor: University of Castilla-La Mancha. Phase: NA. Conditions: Cerebral Palsy
Sponsor: Ain Shams University. Phase: NA. Conditions: Macular Hole Surgery, ILM Peeling, Tenon Capsule, ILM Flap, Macular Hole
Sponsor: AbbVie. Phase: PHASE1. Conditions: Hematologic Cancer
Sponsor: Marmara University. Phase: NA. Conditions: Overweight and Obesity
Sponsor: University of Pennsylvania. Phase: NA. Conditions: Morbidity;Perinatal
Sponsor: Cairo University. Phase: . Conditions: Osteoporosis
Sponsor: Oslo University Hospital. Phase: NA. Conditions: Anorexia Nervosa
Sponsor: Fundacion Dexeus. Phase: NA. Conditions: Infertility
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: PHASE1. Conditions: Diet Therapy, Healthy Volunteers
Sponsor: Intra-IMMUSG Pte Ltd. Phase: PHASE2. Conditions: Advanced Malignant Solid Tumor
Sponsor: University of Florida. Phase: NA. Conditions: Carotenoids
Sponsor: Fred Hutchinson Cancer Center. Phase: . Conditions: Chronic Graft Versus Host Disease
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: NA. Conditions: Helicobacter Pylori
Sponsor: University Hospital of North Norway. Phase: NA. Conditions: Stroke
Sponsor: Vanderbilt University Medical Center. Phase: PHASE4. Conditions: Renal Transplant
Sponsor: China-Japan Friendship Hospital. Phase: . Conditions: Uterine Fibroids (Leiomyoma)
Sponsor: Cancer Research Antwerp. Phase: PHASE2. Conditions: Prostate Cancer
Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Mechanical Ventilation, Airway Patency, Respiratory Depression
Sponsor: Fred Hutchinson Cancer Center. Phase: PHASE2. Conditions: Chronic Graft Versus Host Disease
Sponsor: Donald Wesson. Phase: NA. Conditions: Chronic Kidney Diseases, Cardiovascular Diseases, Hypertension
Sponsor: Case Western Reserve University. Phase: NA. Conditions: Recession, Gingival
Sponsor: Universitas Padjadjaran. Phase: NA. Conditions: Stroke (Subacute)
Sponsor: Kocaeli University. Phase: NA. Conditions: Lactation, Breastfeeding, Premature Birth, Maternal Stress, Self-Efficacy
Sponsor: InSightec. Phase: NA. Conditions: Essential Tremor, Neurology
Sponsor: Sam Chun Dang Pharm. Co. Ltd.. Phase: PHASE1. Conditions: Diabetes Mellitus, Type 1
Sponsor: Draig Therapeutics Ltd. Phase: PHASE2. Conditions: Major Depressive Disorder (MDD)
Sponsor: Istinye University. Phase: . Conditions: Motion Sickness, Somatosensory Disorders, Dizziness
Sponsor: Centers for Disease Control and Prevention. Phase: PHASE3. Conditions: Influenza
Sponsor: Cheng-Hsin General Hospital. Phase: NA. Conditions: Bone Age
Sponsor: Mayo Clinic. Phase: . Conditions: Esophageal Neoplasms, Cancer of Esophagus, Cancer of the Esophagus, Esophageal Cancer, Esophagus Cancer, Neoplasm, Esophageal, Esophagectomy, Abnormalities, Digestive System, Digestive System Abnormalities
Sponsor: University of California, San Francisco. Phase: PHASE2. Conditions: Endometriosis, Ovarian Hyperstimulation
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Breast Cancer Survivors
Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Hypermobile Ehlers-Danlos Syndrome, Hypermobile Spectrum Disorder, Ehlers-Danlos Syndrome
Sponsor: Connect Biopharm LLC. Phase: PHASE2. Conditions: Asthma Acute
Sponsor: Istanbul Arel University. Phase: . Conditions: Post-stroke, Dysphagia, Videofluoroscopy, Scale Reliability Validity
Sponsor: Mayo Clinic. Phase: PHASE1. Conditions: Human Papillomavirus-Negative Neck Squamous Cell Carcinoma, Resectable Head and Neck Squamous Cell Carcinoma, Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma, HPV-Negative Squamous Cell Carcinoma, Resectable Head and Neck Squamous-cell Carcinoma
Sponsor: University of Wisconsin, Madison. Phase: PHASE2. Conditions: Facial Filler Injections, Hyaluronic Acid, Tranexamic Acid
Sponsor: AstraZeneca. Phase: PHASE3. Conditions: NSCLC
Sponsor: Yale University. Phase: NA. Conditions: Tourette Syndrome in Adolescence
Sponsor: St. Jude Children's Research Hospital. Phase: PHASE1. Conditions: Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor, Hepatic Tumor, Lymphoma, Wilms Tumor, Rhabdoid Tumor, Clear Cell Carcinoma, Renal Cell Carcinoma, Melanoma, Neuroblastoma, Rhabdomyosarcoma, Non-rhabdomyosarcoma
Sponsor: Hasanuddin University. Phase: . Conditions: Healhty
Sponsor: NYU Langone Health. Phase: NA. Conditions: Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder
Sponsor: University of Pennsylvania. Phase: NA. Conditions: Post-Acute COVID-19, Post-Acute COVID-19 Syndrome, Post-Acute COVID-19 Infection, Long COVID, Long Covid19, Dyspnea, Orthostasis, Cognitive Impairment
Sponsor: Jonsson Comprehensive Cancer Center. Phase: EARLY_PHASE1. Conditions: Prostate Carcinoma, Recurrent Prostate Carcinoma
Sponsor: Capital Medical University. Phase: . Conditions: Alzheimer's Disease
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma, Oropharyngeal Basaloid Carcinoma, Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Posterior Tongue Squamous Cell Carcinoma, Soft Palate Squamous Cell Carcinoma, Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7, Tonsillar Squamous Cell Carcinoma